Security key
H57830103
NLS Pharmaceutics Ltd. - Common Share, Par Value CHF 0.03 Per Share (NLSP)
CUSIP: H57830103
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Share, Par Value CHF 0.03 Per Share
- Total 13F shares
- 8,526,849
- Total 13F value
- $1,848,846
- Share change
- +368,917
- SEC-reported price per share
- $0.22
- Number of holders
- 9
- Value change
- +$80,292
- Number of buys
- 5
- Number of sells
- 2
- Shares outstanding
- 4,220,689
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
9
Top holders
9
NLSP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
NewcelX Ltd. SEC filings
NewcelX Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP H57830103
Recent filing periods:
Ownership snapshot
Top reported holders of NLSP - NLS Pharmaceutics Ltd. - Common Share, Par Value CHF 0.03 Per Share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
7/7
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 136%
Showing 1-6 of 7 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 136%.
7 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
136%
ARMISTICE CAPITAL, LLC
51%
RENAISSANCE TECHNOLOGIES LLC
4.3%
XTX Topco Ltd
0.61%
CITADEL ADVISORS LLC
0.45%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
136%
|
$1,044,828
5,747,126 shares
|
— | 31 Mar 2024 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
51%
|
$390,960
2,172,000 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
4.3%
|
$32,000
179,577 shares
|
— | 31 Mar 2024 |
| XTX Topco Ltd |
13F
Company
|
0.61%
|
$4,653
25,594 shares
|
— | 31 Mar 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.45%
|
$3,487
19,183 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.34%
|
$2,611
14,362 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
8,526,849
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
7
Q2 2024 holders
9
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend